2,080 Shares in U.S. Physical Therapy, Inc. (NYSE:USPH) Bought by Everence Capital Management Inc.

Everence Capital Management Inc. purchased a new position in U.S. Physical Therapy, Inc. (NYSE:USPH – Get Rating) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,080 shares of the company’s stock, valued at approximately $207,000.

Other hedge funds have also recently modified their holdings of the company. Sageworth Trust Co of South Dakota purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter worth $55,000. Cim LLC grew its stake in shares of U.S. Physical Therapy by 11.5% in the fourth quarter. Cim LLC now owns 2,248 shares of the company’s stock worth $210,000 after acquiring an additional 232 shares during the last quarter. Teacher Retirement System of Texas grew its stake in shares of U.S. Physical Therapy by 20.8% in the fourth quarter. Teacher Retirement System of Texas now owns 2,516 shares of the company’s stock worth $240,000 after acquiring an additional 434 shares during the last quarter. Personal CFO Solutions LLC grew its stake in shares of U.S. Physical Therapy by 8.2% in the third quarter. Personal CFO Solutions LLC now owns 2,292 shares of the company’s stock worth $254,000 after acquiring an additional 174 shares during the last quarter. Finally, ProShare Advisors LLC grew its stake in shares of U.S. Physical Therapy by 62.2% in the fourth quarter. ProShare Advisors LLC now owns 3,198 shares of the company’s stock worth $306,000 after acquiring an additional 1,226 shares during the last quarter. 99.13% of the stock is currently owned by institutional investors.

U.S. Physical Therapy stock opened at $107.85 on Thursday. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.08 and a quick ratio of 1.08. U.S. Physical Therapy, Inc. has a one year low of $84.43 and a one year high of $123.38. The stock has a market capitalization of $1.40 billion, a PE ratio of 37.45 and a beta of 1.22. The business’s fifty day moving average is $106.76 and its 200 day moving average is $99.85.

U.S. Physical Therapy (NYSE:USPH – Get Rating) last released its quarterly earnings data on Thursday, May 5th. The company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.63 by $0.02. U.S. Physical Therapy had a return on equity of 14.77% and a net margin of 7.69%. The company had revenue of $131.70 million for the quarter, compared to analysts’ expectations of $128.57 million. During the same period last year, the firm posted $0.64 earnings per share. U.S. Physical Therapy’s revenue was up 17.2% compared to the same quarter last year. As a group, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 3.33 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 14th. Shareholders of record on Monday, May 16th were issued a $0.41 dividend. This represents a $1.64 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date was Friday, May 13th. U.S. Physical Therapy’s dividend payout ratio is 56.94%.

A number of equities research analysts have recently commented on USPH shares. StockNews.com started coverage on U.S. Physical Therapy in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. Barrington Research cut their target price on U.S. Physical Therapy from $144.00 to $123.00 in a research note on Friday, February 25th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $121.50.

About U.S. Physical Therapy (Get Rating)

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also